Vascular-Targeted Photodynamic Therapy Using WST11 in Patients With Localized Prostate Cancer.
Phase of Trial: Phase II
Latest Information Update: 24 Oct 2015
At a glance
- Drugs Padeliporfin (Primary)
- Indications Prostate cancer
- Focus Therapeutic Use
- Sponsors Steba Biotech
- 10 Jun 2017 Biomarkers information updated
- 14 Sep 2012 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 05 Jul 2012 Planned end date changed from 1 Apr 2012 to 1 Sep 2012 as reported by ClinicalTrials.gov.